Xiaoming Jia, MD
Interventional Cardiology · Houston, TXNPI 1932586948
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Abbott at 36.1% of the total. Reporting peaked in 2022 at $1,810 and has fallen 81.2% since, to $340 in 2025. That places this record below the midpoint for interventional cardiology clinicians in TX, where the typical reported total is $9,094.
Across 95 payments — averaging $50.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$944
- Abiomed$450
- Philips North America LLC$237
- Amgen$235
- Teleflex LLC$158
- plus $1K from 12 others
Across 1 payment — averaging $1827.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$2K
What the payments were for
- Travel & lodging$1253%
- Food & beverage$4,61596%
- Education$701%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 23 | $1,738 |
| Boston Scientific | 16 | $944 |
| Abiomed | 5 | $450 |
| Philips North America LLC | 2 | $237 |
| Amgen | 12 | $235 |
| Teleflex LLC | 8 | $158 |
| Shockwave Medical, Inc | 1 | $148 |
| Cardiovascular Systems Inc. | 1 | $148 |
| Inari Medical, Inc. | 1 | $146 |
| AstraZeneca | 6 | $146 |
| GE HealthCare | 2 | $124 |
| Pfizer | 5 | $89 |
| Chiesi USA, Inc. | 4 | $66 |
| Novartis | 3 | $57 |
| Johnson & Johnson | 2 | $40 |
| Cardiva Medical, Inc. | 1 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Medtronic | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUADRA ASSURA$672
- Impella$412
- Perclose ProGlide suture mediated closure system$178
- Quadra Assura CRT Defibrillator$172
- Fortify Assura, Ellipse ICD$166
- CardioMEMS HF System$148
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$148
- Diamondback Coronary$148
- FLOWTRIEVER CATHETER, S$146
- CT THROMBECTOMY SYSTEM KIT$146
- (7881) Ultrasound Und$125
- iLab Ultrasound Imaging System$122
- Samurai RC$114
- ILAB$113
- (9520) IGT Devices Undivided$112
- SYNERGY$111
How this compares
$4,810 in reported general payments places this provider in the 25th percentile of 686 interventional cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ranolazine ErRanolazine | 12 | $919 |
| Rosuvastatin Calcium | 11 | $491 |
| ClopidogrelClopidogrel Bisulfate | 13 | $218 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $154 |
| Atorvastatin Calcium | 15 | $119 |
| Lisinopril | 14 | $49 |
| Losartan Potassium | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Houston
- Juan GranadaHouston$4.1M
- John IsaacHouston$1.8M
- Sanjay KunapuliHouston$267K
- Michele SartoriHouston$266K
- Abhijeet DhobleHouston$161K
- Amir KashaniHouston$148K
- Dhaval ParekhHouston$137K
- Neal KleimanHouston$118K
- Mehran MassumiHouston$114K
- Eduardo HernandezHouston$112K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.